Rapid Resolution of Chronic Back Pain with Magnesium Glycinate in a Pediatric Patient | OMICS International | Abstract
ISSN: 2167-0846

Journal of Pain & Relief
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Rapid Resolution of Chronic Back Pain with Magnesium Glycinate in a Pediatric Patient

Christine Lamontagne1*, John A Sewell2, Régis Vaillancourt2 and Cyrus Kuhzarani3,4
1Children’s Hospital of Eastern Ontario
2School of Pharmacy, University of Waterloo
3Pure Lab Vitamins Inc.
4Desjardins Pharmacy
Corresponding Author : Christine Lamontagne
Director of Acute and Chronic Pain Services
Department of Anesthesiology
CHEO, Assistant Professor of Anesthesia
University of Ottawa, Canada
Tel: +1 313 577 3231
Fax: 613-738-4815
E-mail: [email protected]
Received January 02, 2012; Accepted January 10, 2012; Published January 16, 2012
Citation: Lamontagne C, Sewell JA, Vaillancourt R, Kuhzarani C (2012) Rapid Resolution of Chronic Back Pain with Magnesium Glycinate in a Pediatric Patient. J Pain Relief 1:101. doi: 10.4172/2167-0846.1000101
Copyright: © 2012 Lamontagne C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


A 10-year-old male presented to a pediatric complex chronic pain clinic with debilitating back pain associated with vertebral compression fractures secondary to corticosteroid-induced osteoporosis. The pain failed to respond to routine analgesics and zoledronic acid. Oral magnesium glycinate and topical magnesium/guaifenesin cream were initiated upon presentation to the clinic, and resulted in a rapid and sustained reduction in pain, increased flexibility and improved quality of life. Magnesium is a known N-methyl-D-aspartate receptor antagonist, and should be considered in the management of chronic pain. The roles of glycine and guaifenesin in the management of chronic pain are not well-understood, but may warrant further examination in the context of chronic pain.